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ABSTRACT 
Objectives: Accurate gestational age (GA) estimation, preferably by ultrasound measurement 
of fetal crown rump length before 14 weeks’ gestation, is an important component of high-
quality antenatal care.  The objective was to determine how GA can best be estimated by fetal 
ultrasound for women who present for the first time late in pregnancy with uncertain or 
unknown menstrual dates. 
Methods: INTERGROWTH-21st was a large, prospective, multicentre, population-based project 
performed in eight geographically defined urban populations.  One of its principal 
components, the Fetal Growth Longitudinal Study (FGLS), aimed to develop international fetal 
growth standards. Each participant had certain menstrual dates confirmed by first trimester 
ultrasound. Fetal head circumference (HC), biparietal diameter (BPD), occipitofrontal diameter 
(OFD), abdominal circumference (AC) and femur length (FL) were measured every 5 weeks 
from 14 weeks’ gestation until birth. For each participant, a single, randomly selected 
ultrasound examination was used to explore all candidate biometric variables and 
permutations to build models to predict GA. Regression equations were ranked based upon 
minimization of the mean prediction error, goodness of fit and model complexity. An 
automated machine learning algorithm, the Genetic Algorithm, was adapted to evaluate 
>64,000 potential polynomial equations as predictors. 
Results: Of the 4607 eligible women, 4321 (94%) had a pregnancy without major complications 
and delivered a live singleton without congenital malformations. After other exclusions 
(missing measurements in GA window and outliers), the final sample comprised 4229 women. 
Two skeletal measures, HC and FL, produced the best GA prediction, given by the equation  
loge (GA) = 0.03243 x [loge(HC)]2 + 0.001644 x FL x logeHC + 3.813 
When FL is not available, the best equation based on HC alone is 
loge(GA) = 0.05970 x [loge(HC)]2 + 0.000000006409 x HC3 + 3.3258 
The estimated uncertainty of GA prediction (95% interval) was 6 to 7 days at 14 weeks’ 
gestation, 12 to 14 days at 26 weeks’ gestation, and over 14 days in the third trimester. The 
addition of FL to HC leads to improved prediction intervals over just using HC, but no further 
improvement in prediction is afforded by adding AC, BPD or OFD. Equations that included 
other measurements (BPD, OFD and AC) did not perform better. 
Conclusions: Among women initiating antenatal care late in pregnancy a single set of 
ultrasound measurements combining HC and FL in the second trimester can be used to 
estimate GA with reasonable accuracy. We recommend this tool for underserved populations 
but considerable efforts should be implemented to improve early initiation of antenatal care 
worldwide.  
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INTRODUCTION   
Reliable estimation of gestational age (GA) is essential as it allows appropriate scheduling of a 
woman’s antenatal care, informs obstetric management decisions and facilitates the correct 
interpretation of fetal growth assessment [1]. Abnormal fetal growth patterns such as growth 
restriction or macrosomia may be missed or incorrectly diagnosed if GA is unknown or 
incorrect. Reliable GA estimation is also important at a population level to calculate rates of 
preterm birth and small for gestational age (SGA) at birth. The lack of accurate GA estimation, 
particularly in geographical regions at greatest risk of these conditions, means that preterm 
birth and SGA rates are mere approximations in many parts of the world [2, 3]. 
Traditionally, GA is estimated using the first day of the last menstrual period (LMP), which 
assumes that ovulation occurs on day 14 of the menstrual cycle. Irregular menses, unknown or 
uncertain dates, oral contraceptive use or recent pregnancy or breastfeeding may all influence 
the accuracy of this method - issues that occur in a large proportion of women [4-6].  In such 
cases, early (<14 weeks’ gestation) ultrasound measurement of fetal crown rump length (CRL) 
is recommended [7,8]. First trimester GA assessment is more accurate than dating in late 
pregnancy because, with advancing gestation, fetal ultrasound measurements have a larger 
absolute error [9] and growth disturbances become more noticeable, resulting in potential 
underestimation of GA for an abnormally small fetus and overestimation for a macrosomic 
fetus.  
Unfortunately, in many settings where high-risk pregnancies are prevalent, women attend 
their first antenatal care visit late in pregnancy or even at the time of delivery. This makes it 
difficult to manage complications, evaluate fetal growth and implement evidence-based 
interventions, such as the administration of corticosteroids for fetal lung maturation in cases 
of threatened preterm labour.  
The present analysis of the Fetal Growth Longitudinal Study (FGLS), one of the main 
components of the INTERGROWTH-21st Project, aims to complement our previous work of 
early GA estimation by ultrasound measurement of CRL [10]. We have explored a set of 
equations to estimate GA using fetal biometry acquired during a single ultrasound scan 
performed between 14 and 34 weeks’ gestation.     
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METHODS 
INTERGROWTH-21st is a multicentre, multiethnic, population-based project, conducted 
between 2009 and 2014 in eight countries [11]. Its primary aim was to study growth, health, 
nutrition and neurodevelopment from <14 weeks’ gestation to 2 years of age, using the same 
conceptual framework as the WHO Multicentre Growth Reference Study (MGRS) [12,13].  
Eight urban areas located at low altitude (≤1,600m) were chosen as study sites, within which 
we selected all institutions providing pregnancy and intrapartum care where >80% of 
deliveries occurred. Women receiving antenatal care had to plan to deliver in these institutions 
or in a similar hospital located in the same geographical area and there had to be an absence 
or low levels of major, known, non-microbiological contamination such as pollution, domestic 
smoke, radiation or any other toxic substances [14].    
Women from these populations, with a singleton pregnancy that was conceived naturally, and 
who met the individual inclusion criteria, were recruited prospectively and consecutively into 
FGLS.  The study methods have been described in detail elsewhere [11,15].   
The true gestational age (GAtrue) was defined by the woman’s LMP determined at the first visit 
at <14+0 weeks’ gestation, provided that: (1) the date was certain; (2) she had a regular 24–32 
day menstrual cycle; (3) she had not been using hormonal contraception or breastfeeding in 
the preceding 2 months, and (4) it was in agreement (within 7 days) with a measurement of 
fetal CRL at 9+0 to 13+6 weeks’ gestation [15].   
A single ultrasound machine (Philips HD-9; Philips Ultrasound, Bothell, WA, USA) with 
curvilinear abdominal transducers (C5-2, C6-3, V7-3) was used for all fetal measurements ≥14+0 
weeks’ gestation. To reduce expected value bias, the ultrasound machines were specially 
adapted so that the measurements were not visible on the screen. However, as women 
presented for their first visit at different clinics within the geographical area, for those 
ultrasound scans done <14+0 weeks’ gestation (CRL measures only), it was considered 
acceptable to use other, locally available, machines provided they were evaluated and 
approved by the study team.  All ultrasonographers (n=39) at the eight study sites underwent 
rigorous training and standardization. In accordance with the protocol, CRL and fetal biometry 
measures were assessed for quality; the former were also reviewed blindly by our 
collaborators at the Société Française pour l'Amélioration des Pratiques Echographiques 
(SFAPE) [16,17]. 
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Women were invited for follow-up ultrasound scans every 5 weeks (within one week either 
side) after the initial dating scan, so that the possible ranges after the dating scan were 14-18, 
19-23, 24-28, 29-33, 34-38 and 39-42 weeks’ gestation.  At each visit, fetal head circumference 
(HC), biparietal diameter (BPD), occipitofrontal diameter (OFD), abdominal circumference (AC) 
and femur length (FL) were measured three times from three separately obtained ultrasound 
images of each structure [18].  
Head measurements were taken in an axial view at the level of the thalami, with an angle of 
insonation as close as possible to 90°. The head had to be oval in shape, symmetrical, centrally 
positioned and filling at least 30% of the monitor. The midline echo (representing the falx 
cerebri) had to be broken anteriorly, at one-third of its length, by the cavum septi pellucidi. 
The thalami had to be located symmetrically on either side of the midline. Callipers were then 
placed on the outer border of the parietal bones (‘outer to outer’) at the widest or longest part 
of the skull for the BPD and OFD, respectively; the HC was measured using the ellipse facility 
on the outer border of the skull.  
The measurements of the fetal abdomen were taken in a cross-sectional view (as close as 
possible to a circle), with the umbilical vein in the anterior third of the abdomen (at the level of 
the portal sinus), and the stomach bubble visible. The operator was instructed to avoid 
applying too much pressure with the transducer as this can distort the circular shape of the 
fetal abdomen. The abdomen had to fill at least 30% of the monitor screen; the spine had 
preferably to be positioned at either 3 or 9 o'clock to avoid internal shadowing; the kidneys 
and bladder had not to be visible. For the measurements, the contour of the ellipse was placed 
on the outer border of the abdomen.  
Finally, the FL was measured using a longitudinal view of the fetal thigh closest to the probe 
and with the femur as close as possible to the horizontal plane. The angle of insonation of the 
ultrasound beam was approximately 90° with the full length of the bone visualised, 
unobscured by shadowing from adjacent bony parts, and the femur had to fill at least 30% of 
the monitor screen. The intersection of the callipers was placed on the outer borders of the 
edges of the femoral diaphysis (outer to outer) ensuring clear femoral edges.  
Detailed measurement protocols, standardization procedures and quality control methods 
employed across all sites are described in detail elsewhere [15,19-21].  
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Statistical analysis 
For each woman included in the study, a single ultrasound scan between 14+0 and 40+0  
weeks’ gestation was randomly selected using the ‘sample’ function in Stata (version 13). At 
each scan, the routinely measured fetal biometric variables were recorded. To overcome the 
problem of data truncation at the lower end of gestation (<14+0 weeks), we followed the same 
approach previously described and applied to CRL data [22]. Using the international fetal 
growth equations for head circumference, abdominal circumference, femur length, biparietal 
diameter and occipito-frontal diameter [18], we simulated 20 observations for each day 
between 12+0 and 13+6 weeks’ gestation (n=280), which is approximately the same number of 
observations for each day of GA in the un-truncated data set. After simulation, we restricted 
the data based on head circumference by excluding values below 85mm or above 330mm and 
visually inspecting a plot of the data to assess that the truncation problem had been 
overcome.  Using the augmented data set, fractional polynomial regression analyses were 
employed using the Xrigls function in Stata to model the mean and standard deviation (SD) of 
GA for each biometric variable [22].  
In order to establish the relationship of fetal biometric variables and gestational age we used 
an automated machine learning, ‘Genetic Algorithm’ (see Appendix). This method was chosen 
because a more traditional fractional polynomial approach, which is well suited to modelling a 
single variable, has limited scope when used with multiple biometric variables that are highly 
correlated. By virtue of the automated approach, the Genetic Algorithm is able to evaluate 
large numbers (in this case over 64,000) of potential combinations of biometric variables that 
are used to build polynomial equations as predictors of GA; this would not be feasible using 
conventional approaches. By specifying a mathematical definition of optimal performance, 
based upon minimization of the mean prediction error (root mean squared error, RMSE), the 
first stage of model development was entirely automated with the capacity to assemble, 
evaluate and modify equations. We were, therefore, able to use the data themselves to 
generate preliminary models in an entirely objective manner.  
Briefly, a large number of preliminary candidate equations were developed using combinations 
of all candidate biometric variables (including powers (0.5, 1, 2 and 3), their logs and their 
products). Each of the candidate equations was used to obtain for each fetus a predicted 
gestational age (GApredicted) as an estimate of their true gestational age (GAtrue). After 
preliminary analysis it was clear that the predicted values GApredicted were not normally 
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distributed; this was addressed by predicting the natural logarithm of GApredicted (logeGApredicted). 
The equations were then ranked to assess which had the lowest uncertainty based on the 95% 
prediction interval. 
We used a 4-step approach to determine our final equation (see Appendix for more detailed 
explanation):  
1. Equation discovery using the Genetic Algorithm: The automated Genetic Algorithm 
was used to determine the equation providing the best prediction of GA using 
combinations of fetal biometric variables. Briefly, the model initiated itself by assigning 
polynomial equations linking fetal biometry within the dataset and GAtrue. Model 
terms, coefficients and powers were randomly selected within specified limits. Once 
defined, the individual equations were each used to predict GAtrue using the observed 
fetal biometry data. The performance of individual equations was measured by 
calculating the RMSE between the true and predicted GA at each iteration of the 
genetic algorithm. For each combination of biometric variables, the equation with the 
lowest RMSE was selected automatically and modified by methods that mimic the 
genetic principles of mutation and cross-over. Thus, a second generation of equations 
was developed with the ‘positive predictive qualities’ of the first generation preserved 
in their structure. Furthermore, random variation was introduced as ‘mutations’ into 
the best performing equations in order to assess whether such mutations conferred an 
advantage in prediction, evaluated using the RMSE. By repeating the process over 
many iterations, the structure of equations was continuously refined until there was 
convergence upon the equation, or series of equations, that most accurately predicted 
GAtrue. All data processing at this stage was performed using the `GAPolyfitn’ function 
in MATLAB version R2014b.  
2. Goodness of fit.   
Visual inspection of scatter plots was used to compare GAtrue with GApredicted for each 
candidate equation obtained from the genetic algorithm.  Quantile-Quantile (QQ) plots 
were used to compare the distributions.  Well-fitting models were identified by a QQ 
plot with minimal deviation from the line of equality. 
For each equation, absolute residuals between GAtrue – GApredicted were regressed on GA 
using fractional polynomial methods (powers +/- 0.5, 1, 2 and 3) to provide an 
equation that approximated the SD, and multiplied by a constant to estimate the 2.5th 
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and 97.5th centiles using the Xrigls function in Stata (Altman DG. Construction of age-
related reference centiles using absolute residuals. Stat Med 1993;12:917-924).. The 
goodness of fit of these estimated SDs was assessed by calculating the proportion of 
predicted GAs that were outside the 95% prediction intervals (±1.96SD), which should 
be 5%.   
3. Evaluation of model complexity 
To facilitate a suitable balance between parsimony and model performance, estimates 
of Akaike’s Information Criterion (AIC) [23] were calculated and compared.  The AIC 
combines an estimate of the goodness of fit of a model with a penalty for increasing 
model complexity. In addition, candidate equations with similar indices were 
compared in terms of number of terms and complexity, defined as the sum of the 
powers of each variable). Where two equations demonstrated similar performance, 
the equation with a less complex structure was preferred.  
4. Post-production model refinement 
After examining the model complexity, it appeared that most of the contribution to 
the prediction of GA was based on HC. Therefore, simplified models were constructed, 
restricted to biometry of the fetal head (HC, OFD and BPD).   
The INTERGROWTH-21st Project was approved by the Oxfordshire Research Ethics Committee 
“C” (ref: 08/H0606/139), the research ethics committees of the individual participating 
institutions, as well as the corresponding regional health authorities where the project was 
implemented. 
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Results 
Of the 4,607 women recruited into FGLS, 4,321 delivered live singletons without congenital 
malformations (Figure 1). Exclusions were women with missing fetal measurements (n=84), 
and outliers defined as fetal measurements >5 SD above/below the mean (n=7). We further 
restricted the actual data at the top end by excluding head circumference values above 
330mm (n=1) resulting in a total of 4,229 women who contributed a single, randomly selected 
ultrasound scan between 14+0 and 40+0 weeks’ gestation (Figure 1). Of the 280 observations 
simulated and added to actual data, we similarly excluded head circumference values below 
85mm (n=148) to obtain the final analysis sample of 4,361 observations. The baseline 
characteristics and perinatal events of the study population (n=4,229 excluding simulated 
observations) are shown in Table 1.  
The equations that best estimated GAtrue based on lowest RMSE, best fit and optimal AIC are 
shown in Table 2. Equations selected were based on HC alone, and a combination of HC and 
FL; despite including multiple measures (HC, BPD, OFD, AC, FL) in the models, only HC and FL 
were retained after the selection process. 
Overall, based on a model using HC only, the uncertainty of estimated GA gradually  with 
advancing GA, from 6 to 7 days in either direction at 14+0 weeks to 14 to 18 days at 32+0 weeks’ 
gestation (Table 3). Inclusion of FL led to an improvement in prediction throughout gestation 
of about 1-3 days. Inclusion of the other parameters led to no further improvement, and so 
none were included in the equations resulting from the Genetic Algorithm search. 
The plots of GApredicted versus GAtrue between 14+0 and 34+0 weeks’ gestation demonstrated 
good model fitting (Figures 2 and 3 for the scatterplots and Figures S4 and S5 for the QQ plots). 
Apart from estimating the most likely GA (by using GApredicted for a set of measurements), we 
also present the lower and upper bounds of the estimation of GA (Table 4). The lower bound 
can be used in clinical management for women who present in late pregnancy: it is an estimate 
of the likely “least GA”, e.g. 97.5% likely to be at least X weeks. 
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Discussion 
Main findings 
We have shown that a single set of basic ultrasound measurements of HC and FL in the second 
trimester can be used to estimate GA with reasonable accuracy. The estimation is best at 
lower GAs where the 95% prediction interval is within 6 days, but is just over 12 days at 26+0 
weeks’ gestation. The addition of FL to HC leads to considerable improvement over just using 
HC, but no further improvement in prediction is afforded by adding AC, BPD or OFD.  
Strengths and weaknesses 
We have produced equations for GA assessment that are more precise than those currently 
used in routine clinical practice (Table 5). This may be due to the prospective nature of the 
study; a large sample size; accurately dated pregnancies; a clearly defined measurement 
protocol; quality control measures, and a statistical approach that searched for the optimal 
combination of factors iteratively, rather than relying upon a user-controlled search. The 
multicentre, international setting of the study with measurements taken by a large group of 
ultrasonographers provides external validity.  
There is an intrinsic limitation when estimating GA by fetal anthropometric based equations: 
namely that what is measured is fetal size not GA. Fetal size may vary for reasons other than 
differences in GA especially as factors conditioning abnormal fetal growth are more prevalent 
in the populations where the equation is most likely to be used. In other words, it is important 
to take into account the impact of pathology (fetal growth restriction and overgrowth) on GA 
estimation. This is true for any equation estimating GA – the accuracy at an individual level will 
depend on the ‘normality’ of the fetal size and, at the population level, on the prevalence of 
abnormal growth patterns. Thus, efforts should focus on modifying health systems and referral 
pathways to prevent late presentation in pregnancy, rather than simply achieving 
technological advances in fetal size-based dating. 
Interpretation 
Ultrasound assessment of GA is performed assuming that fetal size can be used as a proxy for 
GA. This assumption depends on: a) the GA at which biometry is performed (at earlier GAs 
growth is more uniform and there is less measurable growth impairment); b) the choice of 
biometric variable, and c) the accuracy of the measurement, which is affected by technical 
aspects of imaging and operator skill.  
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The most accurate way to estimate GA is by measuring fetal CRL between 8+0 and 14+0 weeks’ 
gestation, which is associated with a 95% prediction interval of 2.7 days [24,10]. This method is 
the basis of recommended pregnancy dating policies throughout much of the developed world 
[25]. Beyond 14+0 weeks’ gestation, fetal flexion limits the accuracy of CRL measurements for 
dating purposes and GA estimates are based on measurement of the HC, BPD, AC, FL or a 
combination of these [8, 26].  
Our results demonstrate the relative inaccuracy of late GA assessment, which is due to the 
increasing biological variability in fetal size as well as the increasing absolute error of fetal 
measurements with advancing GA [9]. Therefore, all information (clinical and imaging) should 
be considered when dating pregnancies and providing obstetric care – particularly after late 
pregnancy dating. Thus, we recommend that the following principles should be applied in 
clinical practice:  
- Assessment of fetal age should be based on the earliest available ultrasound 
measurement after 8+0 weeks’ gestation, provided the measurements are technically 
adequate. CRL should be used before 14+0 weeks’ gestation and equation 2 (HC and FL) 
after 14+0 weeks but before 26+0 weeks’ gestation. In settings where HC only is 
available then equation 1 can be used. 
- If menstrual dates are reliable and within the prediction limits of the fetal 
measurement, ultrasound should merely confirm the GA assessed by LMP.  
- When menstrual dates are reliable and fall outside the prediction interval of 
ultrasound assessment there are two interpretations: the menstrual dates are 
incorrect and GA should be based on ultrasound measurement; or the GA is correct as 
assessed by LMP and the fetus is an abnormal size for that GA (or both). Clinical 
features of growth restriction, e.g. reduced amniotic fluid or abnormal uterine or 
umbilical artery blood flow, should be taken into consideration, as should factors that 
may lead to overgrowth, e.g. maternal diabetes. An interval ultrasound scan should 
then be carried out to confirm GA.  
- When menstrual dates are unknown, GA estimation should be based on ultrasound, 
which has reasonable accuracy until 26+0 weeks’ gestation; and a further ultrasound 
scan should be carried out.  
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Finally, when GA is estimated in the third trimester, the possible error is large and must be 
taken into account to ensure safe obstetric practice. The use of the concept of a “minimum” 
GA, by using the lower limit of the prediction interval from the equation can be useful in this 
instance (Table 4). For example, if a woman presents in threatened preterm labour and the 
ultrasound examination suggests a median GA of 34+6 based on HC and FL, it should be 
appreciated that the GA could be as low as 32+6 weeks. i.e. “it is most likely that the GA is 34+6 
weeks, but we are 95% certain that the GA is at least 32+6 weeks. However, if the fetus is 
growth restricted, the GA could be as much as 36+5 weeks.” This analysis is very relevant to 
clinical decision making: for example, when administering prophylactic corticosteroids or 
transferring a neonate to a higher level of care. In contrast, labour induction may be 
considered at 40+0 weeks’ gestation based on late assessment, as the GA could be more 
advanced. Such a clinically cautious approach is particularly important as it is known that 
unreliable reporting of LMP and late antenatal care are both associated with adverse 
pregnancy outcomes [5, 27].  
Conclusion 
We have shown that a single set of ultrasound measurements in the second trimester can be 
used to estimate GA with relative accuracy. We recommend these tools for the management 
of women who present late in pregnancy. However, we strongly encourage as a priority the 
promotion of early antenatal care in regions and sub-populations that are not yet benefitting 
from this practice.  
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Figure 1: Flow chart of recruitment through the study. 
 
Figure 2: Scatterplot showing the estimation of gestational age based on fetal head 
circumference at 14 to 34 weeks of true gestational age. The black line is the line of equality; 
the red lines are ±2SD.   
Figure 3: Scatterplot showing estimation of gestational age based on fetal head circumference 
and femur length at 14 to 34 weeks of true gestational age. The black line is the line of 
equality; the red lines are ±2SD.   
Supplementary figures S4-S5: Q-Q plots to assess the goodness of fit of the models for head 
circumference (S4); and head circumference and femur length (S5). 
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78 excluded due to miscarriage,  pregnancy 
termination or stillbirth 
Number enrolled and consented 
into FGLS
(n=4,607)
Women with pregnancy
and delivery information
(n=4,500)
Livebirths
(n=4,422)
Born alive without congenital 
malformation                                      
(n=4,321)
71 Lost to follow-up or withdrew consent
36 Excluded due to severe maternal disorders 
(29), smoking (6), recreational drug use (1)
At least 1 eligible scan between 
14-40 weeks                           
(n=4,229)
101 livebirths with congenital
malformation
• 84 with no fetal measurements
• 7 outliers (> 5SD of the respective mean 
fetal measurement)
• 1 subject with head circumference >330mm
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Table 1: Baseline characteristics and perinatal events of the study population of 4229 women 
 
Characteristic Mean (SD) or n (%) 
Maternal age, years 27.8 (3.8) 
Maternal height, cm  162.2 (5.8) 
Maternal weight, kg 61.5 (9.2)
Body mass index, kg/m2 23.2 (3.0) 
Gestational age at first visit, weeks  11.3 (1.4) 
Nulliparous 2815 (68.6%) 
Pre-eclampsia  31 (<1%)
Preterm birth (<37 weeks) 189 (4.5%) 
Term LBW less than 2500g (≥37 weeks)  127 (3%) 
Male sex 2101 (49.7%) 
Birth weight (≥37 weeks), kg 3.3 (0.4)
 
 
Maternal baseline characteristics were measured at less than 14 weeks’ gestation. LBW = low birth 
weight. 
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Table 2: Selected equations for late gestational age estimation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GA: exact estimated gestational age (days) 
HC: Head Circumference (mm)   
FL: Femur Length (mm) 
loge = Logarithm to base e (natural logarithm) 
SD = standard deviation    
 
For example, to calculate gestational age using equation 1: 
If HC is 250mm  
median GA  = exp (0.05970* [loge(250)]2 + 0.000000006409*2503 + 3.3258 
  = exp (5.245986506) 
  = 189.8 days (equivalent to 27.1 weeks) 
 
To calculate gestational age using equation 2,  
If HC is 250mm and FL is 55mm 
median GA  = exp 0.03243 x [loge(250)]2 + 0.001644 x 55 x loge(250) + 3.813 
  = exp (5.300929) 
  = 200.5 days (equivalent to 28.6 weeks) 
 
Using equations of the median and standard deviation one can easily compute any desired centiles 
using the relation Pth centile = Median + KSD, where K is the normal equivalent deviate (z score) 
corresponding to a particular centile, e.g. K = 1.88 for the 97th centile and −1.88 for the 3rd cenƟle. 
The SDs in this equation are the predicted estimates from the regression analysis. 
 
For example, 3rd centile for GA = exp (0.05970*(logeHC)2 + 0.000000006409*HC3 + 3.3258) + (-
1.88*(0.6492* (Median GA*0.01)3 + 2.991)) 
ID Variables 
(mm) 
Equation to estimate logeGA (days) 
1 HC  loge(GA) = 0.05970 x [loge(HC)]2 + 0.000000006409 x HC3 + 3.3258 
2 HC, FL loge(GA) = 0.03243 x [loge(HC)]2 + 0.001644 x FL x loge(HC) + 3.813 
 
ID Variables 
(mm) 
Equation to estimate the standard deviation of GApredicted (days) 
1 HC  SD = 0.6492 x (GA x 0.01)3 + 2.991 
2 HC, FL SD = 0.04009 x GA – 1.149 
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Table 3: Selected equations: goodness of fit characteristics of gestational age assessment in days. 
 
Equation ID  1 2 
Variables  in equation HC HC, FL 
RMSE (log days) 0.0423 0.0352 
R-squared 0.98 0.99 
Goodness of fit (%) 5.21 6.20 
AIC 16.33 14.69 
Variation around the mean of 
GA estimate (half width of 95% 
prediction interval (days), at:  
  
14 weeks 7.1 5.4 
16 weeks 7.7 6.5 
18 weeks 8.4 7.6 
20 weeks 9.4 8.7 
22 weeks 10.5 9.8 
24 weeks 11.9 10.9 
26 weeks 13.5 12.0 
28 weeks 15.4 13.2 
30 weeks 17.6 14.3 
32 weeks 20.1 15.4 
34 weeks 23.0 16.5 
RMSE = root mean squared error.  Goodness of fit = the percentage of predicted estimates of GA 
outside the 95% prediction interval across all gestational ages.  AIC = the Akaike Information Criterion.   
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Table 4: Prediction of gestational age using the two equations. The median (50th centile) is the most likely gestational age in the absence of pathology. The true 
gestational age is unlikely to be below the lower limit of the prediction interval (2.5th centile). Data shown in weeks+days 
 
 
 
Most likely value (50th centile) Lower limit of prediction interval (2.5th centile) Upper limit of prediction interval (97.5th centile) 
 Equation 1 (HC) Equation 2 (HC, FL) Equation 1 (HC) Equation 2 (HC, FL) 
14+0 12+6 13+1 15+0 14+5 
14+1 13+0 13+2 15+1 14+6 
14+2 13+1 13+3 15+2 15+0 
14+3 13+2 13+4 15+3 15+1 
14+4 13+3 13+5 15+4 15+2 
14+5 13+4 13+6 15+5 15+3 
14+6 13+5 14+0 15+6 15+4 
15+0 13+6 14+1 16+0 15+5 
15+1 14+0 14+1 16+1 16+0 
15+2 14+1 14+2 16+2 16+1 
15+3 14+2 14+3 16+3 16+2 
15+4 14+3 14+4 16+4 16+3 
15+5 14+4 14+5 16+5 16+4 
15+6 14+5 14+6 16+6 16+5 
16+0 14+6 15+0 17+0 16+6 
16+1 15+0 15+1 17+1 17+0 
16+2 15+1 15+2 17+2 17+1 
16+3 15+2 15+3 17+3 17+2 
16+4 15+3 15+4 17+4 17+3 
16+5 15+4 15+5 17+5 17+4 
16+6 15+5 15+5 17+6 17+6 
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17+0 15+5 15+6 18+1 18+0 
17+1 15+6 16+0 18+2 18+1 
17+2 16+0 16+1 18+3 18+2 
17+3 16+1 16+2 18+4 18+3 
17+4 16+2 16+3 18+5 18+4 
17+5 16+3 16+4 18+6 18+5 
17+6 16+4 16+5 19+0 18+6 
18+0 16+5 16+6 19+1 19+0 
18+1 16+6 17+0 19+2 19+1 
18+2 17+0 17+1 19+3 19+2 
18+3 17+1 17+2 19+4 19+3 
18+4 17+2 17+3 19+5 19+4 
18+5 17+3 17+3 19+6 19+6 
18+6 17+4 17+4 20+0 20+0 
19+0 17+5 17+5 20+1 20+1 
19+1 17+6 17+6 20+2 20+2 
19+2 18+0 18+0 20+3 20+3 
19+3 18+0 18+1 20+5 20+4 
19+4 18+1 18+2 20+6 20+5 
19+5 18+2 18+3 21+0 20+6 
19+6 18+3 18+4 21+1 21+0 
20+0 18+4 18+5 21+2 21+1 
20+1 18+5 18+6 21+3 21+2 
20+2 18+6 19+0 21+4 21+3 
20+3 19+0 19+1 21+5 21+4 
20+4 19+1 19+1 21+6 21+6 
20+5 19+2 19+2 22+0 22+0 
20+6 19+3 19+3 22+1 22+1 
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21+0 19+4 19+4 22+2 22+2 
21+1 19+5 19+5 22+3 22+3 
21+2 19+5 19+6 22+5 22+4 
21+3 19+6 20+0 22+6 22+5 
21+4 20+0 20+1 23+0 22+6 
21+5 20+1 20+2 23+1 23+0 
21+6 20+2 20+3 23+2 23+1 
22+0 20+3 20+4 23+3 23+2 
22+1 20+4 20+5 23+4 23+3 
22+2 20+5 20+5 23+5 23+5 
22+3 20+6 20+6 23+6 23+6 
22+4 21+0 21+0 24+0 24+0 
22+5 21+1 21+1 24+1 24+1 
22+6 21+1 21+2 24+3 24+2 
23+0 21+2 21+3 24+4 24+3 
23+1 21+3 21+4 24+5 24+4 
23+2 21+4 21+5 24+6 24+5 
23+3 21+5 21+6 25+0 24+6 
23+4 21+6 22+0 25+1 25+0 
23+5 22+0 22+1 25+2 25+1 
23+6 22+1 22+2 25+3 25+2 
24+0 22+2 22+3 25+4 25+3 
24+1 22+3 22+3 25+6 25+5 
24+2 22+3 22+4 26+0 25+6 
24+3 22+4 22+5 26+1 26+0 
24+4 22+5 22+6 26+2 26+1 
24+5 22+6 23+0 26+3 26+2 
24+6 23+0 23+1 26+4 26+3 
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25+0 23+1 23+2 26+5 26+4 
25+1 23+2 23+3 26+6 26+5 
25+2 23+3 23+4 27+0 26+6 
25+3 23+3 23+5 27+2 27+0 
25+4 23+4 23+6 27+3 27+1 
25+5 23+5 24+0 27+4 27+2 
25+6 23+6 24+1 27+5 27+3 
26+0 24+0 24+1 27+6 27+5 
26+1 24+1 24+2 28+0 27+6 
26+2 24+2 24+3 28+1 28+0 
26+3 24+3 24+4 28+2 28+1 
26+4 24+3 24+5 28+4 28+2 
26+5 24+4 24+6 28+5 28+3 
26+6 24+5 25+0 28+6 28+4 
27+0 24+6 25+1 29+0 28+5 
27+1 25+0 25+2 29+1 28+6 
27+2 25+1 25+3 29+2 29+0 
27+3 25+2 25+4 29+3 29+1 
27+4 25+2 25+5 29+5 29+2 
27+5 25+3 25+6 29+6 29+3 
27+6 25+4 25+6 30+0 29+5 
28+0 25+5 26+0 30+1 29+6 
28+1 25+6 26+1 30+2 30+0 
28+2 26+0 26+2 30+3 30+1 
28+3 26+1 26+3 30+4 30+2 
28+4 26+1 26+4 30+6 30+3 
28+5 26+2 26+5 31+0 30+4 
28+6 26+3 26+6 31+1 30+5 
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29+0 26+4 27+0 31+2 30+6 
29+1 26+5 27+1 31+3 31+0 
29+2 26+6 27+2 31+4 31+1 
29+3 27+0 27+3 31+5 31+2 
29+4 27+0 27+3 32+0 31+4 
29+5 27+1 27+4 32+1 31+5 
29+6 27+2 27+5 32+2 31+6 
30+0 27+3 27+6 32+3 32+0 
30+1 27+4 28+0 32+4 32+1 
30+2 27+5 28+1 32+5 32+2 
30+3 27+5 28+2 33+0 32+3 
30+4 27+6 28+3 33+1 32+4 
30+5 28+0 28+4 33+2 32+5 
30+6 28+1 28+5 33+3 32+6 
31+0 28+2 28+6 33+4 33+0 
31+1 28+2 29+0 33+6 33+1 
31+2 28+3 29+1 34+0 33+2 
31+3 28+4 29+1 34+1 33+4 
31+4 28+5 29+2 34+2 33+5 
31+5 28+6 29+3 34+3 33+6 
31+6 29+0 29+4 34+4 34+0 
32+0 29+0 29+5 34+6 34+1 
32+1 29+1 29+6 35+0 34+2 
32+2 29+2 30+0 35+1 34+3 
32+3 29+3 30+1 35+2 34+4 
32+4 29+4 30+2 35+3 34+5 
32+5 29+4 30+3 35+5 34+6 
32+6 29+5 30+4 35+6 35+0 
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33+0 29+6 30+5 36+0 35+1 
33+1 30+0 30+6 36+1 35+2 
33+2 30+1 30+6 36+2 35+4 
33+3 30+1 31+0 36+4 35+5 
33+4 30+2 31+1 36+5 35+6 
33+5 30+3 31+2 36+6 36+0 
33+6 30+4 31+3 37+0 36+1 
34+0 30+4 31+4 37+2 36+2 
34+1 30+5 31+5 37+3 36+3 
34+2 30+6 31+6 37+4 36+4 
34+3 31+0 32+0 37+5 36+5 
34+4 31+1 32+1 37+6 36+6 
34+5 31+1 32+2 38+1 37+0 
34+6 31+2 32+3 38+2 37+1 
35+0 31+3 32+3 38+3 37+3 
35+1 31+4 32+4 38+4 37+4 
35+2 31+4 32+5 38+6 37+5 
35+3 31+5 32+6 39+0 37+6 
35+4 31+6 33+0 39+1 38+0 
35+5 32+0 33+1 39+2 38+1 
35+6 32+1 33+2 39+3 38+2 
36+0 32+1 33+3 39+5 38+3 
36+1 32+2 33+4 39+6 38+4 
36+2 32+3 33+5 40+0 38+5 
36+3 32+4 33+6 40+1 38+6 
36+4 32+4 34+0 40+3 39+0 
36+5 32+5 34+1 40+4 39+1 
36+6 32+6 34+1 40+5 39+3 
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37+0 33+0 34+2 40+6 39+4 
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Table 5 Commonly used dating equations and imprecision of gestational age assessment (half width of 95% prediction intervals) in days.  
 
Reference 
R-squared 12 - 18 
weeks 
18 - 24 
weeks 
24 - 30 
weeks 
30 - 36 
weeks 
Hadlock 
(1984)28 
BPD 0.967 8.3 12.1 15.3 21.6 
HC 0.973 8.3 10.4 14.4 20.9 
AC 0.969 11.6 14.4 15.3 20.7 
FL 0.971 9.7 12.6 14.6 20.7 
HC, BPD 0.974 7.6 10.4 13.9 20.0 
HC, FL 0.976 8.4 10.6 13.9 18.8 
HC, AC 0.98 7.6 9.4 13.0 17.6 
HC, FL, BPD 0.981 7.3 9.5 12.7 17.6 
HC, AC, FL 0.981 8.0 10.2 13.2 17.6 
HC, BPD, AC, FL 0.981 7. 6 9.8 12.6 17.1 
Altman and 
Chitty (1997)29 
HC NR 8.0 13.0 17.0 22.0 
BPD = Biparietal Diameter. HC = Head Circumference.  AC = Abdominal Circumference. FL = Femur Length. NR = Not Reported.  
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Appendix: Details of statistical analytical strategy 
Prediction equations were developed using the ‘Genetic Algorithm’, an iterative, automated machine-
learning methodology, whose source code is readily available (Clegg, 2005)  
http://uk.mathworks.com/matlabcentral/fileexchange/25499-gapolyfitn.  Whilst conventional 
approaches employing fractional polynomial regression are ideally suited for predicting a continuous 
non-linear relationship using single variables (e.g. HC and GA), these methods do not translate easily to 
datasets with multiple variables.  The purpose of the genetic algorithm was to construct and evaluate 
a large number of candidate equations, comprising terms based upon subsets of variables from the 
whole dataset; evaluate their fit of GAtrue automatically, and to present a single, simplified equation 
offering the best fit of GAtrue for a specified number of input variables.     
 
In brief, the process initiated by assembling a generation of 1000 polynomial forms, whose terms 
comprised random combinations of biometric variables.  In accordance with previous work, the 
powers of terms used to construct equations were limited to 0.5, 1, 2 and 3; with equations 
subsequently comprising 2, 3 or 4 terms.  Individual terms were assembled as random combinations of 
variables such that a term with power 2 could either comprise the square of a single variable or the 
product of two separate variables.  
 
The algorithm used a least squares fit to evaluate the coefficients of terms for each equation by 
minimizing the error between GApredict and GAtrue.  The overall model fit for each equation was assessed 
using the RMSE, and a generation of equations compared by ranking according to the RMSE.  Once 
ranked, the top 20 percent of equations were selected for modification and iteration within a second 
round of the algorithm; and the remainder discarded.  The genetic algorithm modified the structure of 
equations using processes designed to mimic natural selection.  Whole terms were exchanged 
between equations (recombination) and the structure of terms was changed at random in 10 percent 
of equations (point mutation), before the fit of equations was re-assessed, as described elsewhere 
(Leardi, 1992; Inza 2001; Clegg, 2005; Gutell 2006).  When the modification of equations provided a 
better fit of GAtrue, equations were conserved and entered a subsequent iteration using the same 
methods.  The search was halted when equation variants failed to improve the RMSE by >10-8 
(specified arbitrarily).    Thus, over many cycles, the genetic algorithm converged upon a single 
polynomial equation that optimally predicted GA for the specified input variables. 
The following data structures were assembled from the INTERGROWTH-21st dataset. Each set of 
candidate variables (A-J) was processed by the genetic algorithm to determine the multivariable 
polynomial equation that produced the lowest RMSE for predicting GA for that specific combination of 
input biometry.  It is emphasized that the models increment by the number of terms and the order 
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with which each variable  is entered has no impact upon the selection of terms featuring in the final 
dataset.    
 
A  HC 
B HC+logeHCx 
C  HC+logeHC+BPD 
D HC+logeHC+BPD+logeBPD 
E  HC+logeHC+BPD+logeBPD+OFD 
F HC+logeHC+BPD+logeBPD+OFD+logeOFD 
G HC+logeHC+BPD+logeBPD+OFD+logeOFD+AC 
H HC+logeHC+BPD+logeBPD+OFD+logeOFD+AC+logeAC 
I HC+logeHC+BPD+logeBPD+OFD+logeOFD+AC+logeAC+FL 
J  HC+logeHC+BPD+logeBPD+OFD+logeOFD+AC+logeAC+FL+logeFL 
 
Variables were entered in their natural and natural log state.  Generic equations were therefore 
generated in the form logeGA = aXbi +bXb+1j +cXb+2k..., with the limits of Xb restricted to produce 
equations of 2, 3 or 4 terms. Hence, the structures of the polynomial equations derived were: 
logeGA = aX10−3 + bX20−3 + constant    (1)  
logeGA = aX10−3 + bX20−3 + cX30−3 + constant   (2)  
logeGA = aX10−3 + bX20−3 + cX30−3 + dX40−3 + constant  (3) 
where: 
a, b, c, d : Coefficients determined by genetic algorithm. 
X1, ...  X4 : Combinations of variables determined by the genetic algorithm.   In the case of Xn, X can 
take the form of a single variable (HCn) or a combination of variables (HCi FLj) where i+j=n.  
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Equations of the forms (1) to (3) were constructed for each combination A-J with the terms of each 
equation restricted to power 2 and subsequently to power 3. Hence, each combination A-J was 
processed to construct a 2 term, 2 power equation as well as a 2 term, 3 power and a 3 term, 2 power 
equation, and so on.  
The output of the modeling process consisted of a polynomial equation and respective performance 
indicators including the RMSE, and regression coefficient (r
2
). For each equation, absolute residuals 
between GAtrue – GApredicted were regressed on predicted GA to provide an equation to 
approximate the SD, and multiplied by the constant 1.96√(π/2), (Altman 1993) to estimate the 2.5th 
and 97.5th centiles using the Xrigls function in Stata. 
The Genetic Algorithm methodology was tested extensively before running analyses.  Specifically, 40 
test datasets were assembled within which single and multiple combinations of the constituent 
variables were replaced by random data generated within the same range as the observed data using 
the ‘runiform’ random number generator in Stata. As an indicator of the robustness of search 
algorithm, the test datasets were used to determine if any of the random variables would be selected 
as predictors of GA by the model. This was not the case.  Repeated cycles of the whole process were 
run to assess the reproducibility of results with identical equations resolved each time. 
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